Explore the words cloud of the AFib-TrainNet project. It provides you a very rough idea of what is the project "AFib-TrainNet" about.
The following table provides information about the project.
Coordinator |
KOBENHAVNS UNIVERSITET
Organization address contact info |
Coordinator Country | Denmark [DK] |
Project website | http://afib.ku.dk/ |
Total cost | 4˙101˙221 € |
EC max contribution | 4˙101˙221 € (100%) |
Programme |
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers) |
Code Call | H2020-MSCA-ITN-2015 |
Funding Scheme | MSCA-ITN-ETN |
Starting year | 2015 |
Duration (year-month-day) | from 2015-09-01 to 2019-08-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | KOBENHAVNS UNIVERSITET | DK (KOBENHAVN) | coordinator | 870˙245.00 |
2 | UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF | DE (HAMBURG) | participant | 747˙649.00 |
3 | ACESION PHARMA APS | DK (KOBENHAVN) | participant | 580˙163.00 |
4 | SIMULA RESEARCH LABORATORY AS | NO (FORNEBU) | participant | 572˙550.00 |
5 | UNIVERSITY OF GLASGOW | UK (GLASGOW) | participant | 546˙575.00 |
6 | UNIVERSITEIT MAASTRICHT | NL (MAASTRICHT) | participant | 510˙748.00 |
7 | CLYDE BIOSCIENCES LIMITED | UK (MOTHERWELL LANARKSHIRE) | participant | 273˙287.00 |
8 | BEN-GURION UNIVERSITY OF THE NEGEV | IL (BEER SHEVA) | partner | 0.00 |
9 | Fondazione Cardiocentro Ticino | CH (Lugano) | partner | 0.00 |
10 | OESTERREICHISCHE AKADEMIE DER WISSENSCHAFTEN | AT (WIEN) | partner | 0.00 |
11 | XENTION CAMBRIDGE | UK (CAMBRIDGE) | partner | 0.00 |
The AFib-TrainNet consortium will enable promising young scientists to become excellent research leaders of the future, capable of fighting the challenges that Atrial Fibrillation (AF) presents to the European population. AF is the most common sustained cardiac arrhythmia, occurring in between 1-2% of the general population. More than 6 million Europeans suffer from this arrhythmia and its prevalence is expected to increase by more than two-fold during the next 40 years due to increased life expectancy. Thus, AF is said to assume epidemic proportions. Current options for pharmacological therapy are limited by both low efficacy and side effects, including lifeâ€threatening ventricular arrhythmias and severe extra-cardiac toxicities. A very limited number of novel AF drug therapies have been introduced in the last 20 years. This imbalance reflects a gap in understanding in both how AF develops and how it can be treated, which thereby limits the development of new medicines. Our ambition with the AFib-TrainNet is to fill this gap by producing new knowledge, leading to critical insight into origins and mechanisms of sustenance of atrial fibrillation. We will accomplish this by developing novel experimental and computational models recapitulating human AF, and employing these models on two very promising atrial biological targets. Experimental models will be instrumental in improving the understanding AF’s underlying mechanisms, and will, along with clinical data, inform state-of-the-art computational models of human atrial electrophysiology. These new tools will permit fresh insight into the molecular, cellular and electrical mechanisms involved in the progression of healthy atria into an AF state. Our endeavor will deliver results which can be leveraged by the pharmaceutical industry to target AF drug development, and the work accomplished in AFib-TrainNet will thus constitute a beacon in the search for new AF medicine.
Periodical Scientific Reports (2) | Documents, reports | 2020-02-28 08:16:54 |
Report on CDE activities (2) | Documents, reports | 2020-02-28 08:16:54 |
Periodic report | Documents, reports | 2020-02-28 08:16:54 |
Final report on training activities | Documents, reports | 2020-02-28 08:16:54 |
Synergy meeting | Other | 2020-02-28 08:16:54 |
Periodical training activities report (2) | Documents, reports | 2020-02-28 08:16:54 |
CDE plan (3) | Documents, reports | 2020-02-28 08:16:54 |
Career and Industry Day | Other | 2020-02-28 08:16:54 |
15 PhD theses | Documents, reports | 2020-02-28 08:16:54 |
Periodical training activities report (3) | Documents, reports | 2020-02-28 08:16:54 |
Periodical Scientific Reports (3) | Documents, reports | 2020-02-28 08:16:54 |
Open Research Data Pilot | Open Research Data Pilot | 2020-02-28 08:16:54 |
Website | Websites, patent fillings, videos etc. | 2020-02-28 08:16:53 |
Progress report | Documents, reports | 2020-02-28 08:16:53 |
CDE plan (2) | Documents, reports | 2020-02-28 08:16:53 |
List of recruited ESRs | Documents, reports | 2020-02-28 08:16:53 |
Periodical training activities report (1) | Documents, reports | 2020-02-28 08:16:53 |
Periodical Scientific Reports (1) | Documents, reports | 2020-02-28 08:16:53 |
Report on CDE activities (1) | Documents, reports | 2020-02-28 08:16:53 |
CDE plan (1) | Documents, reports | 2020-02-28 08:16:53 |
Take a look to the deliverables list in detail: detailed list of AFib-TrainNet deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2017 |
L. Soattin; A. Lubberding; BH. Bentzen; T. Jespersen Adenosine 1 receptor activation plays a proarrhythmic role in rat atrium published pages: ii219-ii220, ISSN: , DOI: |
Poster session abstract / EHRA EUROPACE - CARDIOSTIM 2017 Abstract supplement June 18-21, | 2020-02-28 |
2019 |
Jeppe Egedal Kirchhoff, Mark Alexander Skarsfeldt, Kalai Mangai Muthukumarasamy, Rafel Simó-Vicens, Sofia Hammami Bomholtz, Lea Abildgaard, Thomas Jespersen, Ulrik S. Sørensen, Morten Grunnet, Bo Hjorth Bentzen, Jonas Goldin Diness The KCa2 Channel Inhibitor AP14145, But Not Dofetilide or Ondansetron, Provides Functional Atrial Selectivity in Guinea Pig Hearts published pages: , ISSN: 1663-9812, DOI: 10.3389/fphar.2019.00668 |
Frontiers in Pharmacology 10 | 2020-02-28 |
2019 |
Marta Lemme, Ingke Braren, Maksymilian Prondzynski, Bülent Aksehirlioglu, Bärbel M Ulmer, Mirja L Schulze, Djemail Ismaili, Christian Meyer, Arne Hansen, Torsten Christ, Marc D Lemoine, Thomas Eschenhagen Chronic intermittent tachypacing by an optogenetic approach induces arrhythmia vulnerability in human engineered heart tissue published pages: , ISSN: 0008-6363, DOI: 10.1093/cvr/cvz245 |
Cardiovascular Research | 2020-02-28 |
2019 |
Giommi A, Gurgel AR, Saxena P, Smith GL, Workman AJ An investigation of small conductance Ca2+-activated K+ current (ISK) in rabbit and human atrial cardiomyocytes published pages: 299-300, ISSN: , DOI: |
Abstract / Proc Physiol Soc 43 (2019) PC041 | 2020-02-28 |
2018 |
Marta Lemme, Bärbel M. Ulmer, Marc D. Lemoine, Antonia T.L. Zech, Frederik Flenner, Ursula Ravens, Hermann Reichenspurner, Miriam Rol-Garcia, Godfrey Smith, Arne Hansen, Torsten Christ, Thomas Eschenhagen Atrial-like Engineered Heart Tissue: An In Vitro Model of the Human Atrium published pages: 1378-1390, ISSN: 2213-6711, DOI: 10.1016/j.stemcr.2018.10.008 |
Stem Cell Reports 11/6 | 2020-02-28 |
2018 |
András Horváth, Marc D. Lemoine, Alexandra Löser, Ingra Mannhardt, Frederik Flenner, Ahmet Umur Uzun, Christiane Neuber, Kaja Breckwoldt, Arne Hansen, Evaldas Girdauskas, Hermann Reichenspurner, Stephan Willems, Norbert Jost, Erich Wettwer, Thomas Eschenhagen, Torsten Christ Low Resting Membrane Potential and Low Inward Rectifier Potassium Currents Are Not Inherent Features of hiPSC-Derived Cardiomyocytes published pages: 822-833, ISSN: 2213-6711, DOI: 10.1016/j.stemcr.2018.01.012 |
Stem Cell Reports 10/3 | 2020-02-28 |
2018 |
Márcia Vagos, Ilsbeth G. M. van Herck, Joakim Sundnes, Hermenegild J. Arevalo, Andrew G. Edwards, Jussi T. Koivumäki Computational Modeling of Electrophysiology and Pharmacotherapy of Atrial Fibrillation: Recent Advances and Future Challenges published pages: , ISSN: 1664-042X, DOI: 10.3389/fphys.2018.01221 |
Frontiers in Physiology 9 | 2020-02-28 |
2018 |
Arne van Hunnik, Stef Zeemering, Piotr Podziemski, Jorik Simons, Giulia Gatta, Laura Hannink, Bart Maesen, Marion Kuiper, Sander Verheule, Ulrich Schotten Stationary Atrial Fibrillation Properties in the Goat Do Not Entail Stable or Recurrent Conduction Patterns published pages: , ISSN: 1664-042X, DOI: 10.3389/fphys.2018.00947 |
Frontiers in Physiology 9 | 2020-02-28 |
2018 |
Rafel Simó-Vicens, Sofia H. Bomholtz, Ulrik S. Sørensen, Bo H. Bentzen 2,6-Bis(2-Benzimidazolyl)Pyridine (BBP) Is a Potent and Selective Inhibitor of Small Conductance Calcium-Activated Potassium (SK) Channels published pages: , ISSN: 1663-9812, DOI: 10.3389/fphar.2018.01409 |
Frontiers in Pharmacology 9 | 2020-02-28 |
2018 |
Rikke Buhl, Helena Carstensen, Eva Zander Hesselkilde, Bjørg Zinkernagel Klein, Karen Margrethe Hougaard, Kirsten Bomberg Ravn, Ameli Victoria Loft-Andersen, Merle Friederike Fenner, Christian Pipper, Thomas Jespersen Effect of induced chronic atrial fibrillation on exercise performance in Standardbred trotters published pages: 1410-1419, ISSN: 0891-6640, DOI: 10.1111/jvim.15137 |
Journal of Veterinary Internal Medicine 32/4 | 2020-02-28 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "AFIB-TRAINNET" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "AFIB-TRAINNET" are provided by the European Opendata Portal: CORDIS opendata.